No Data
Kangtuo Medical (688314.SH) is distributing equity for the first three quarters of 2024: 0.18 yuan per share will be distributed, with the equity registration on December 3.
Kangtuo Medical (688314.SH) announced the profit distribution for the first three quarters of 2024; this profit distribution is based on...
Kangtuo Medical (688314.SH): Personalized polyether ether ketone skull defect repair prosthesis obtained medical instrument registration certificate.
Concord Medical (688314.SH) announced that the company recently obtained the third pharmaceutical product...
Kangtuo Healthcare: Xi\'an Kangtuo Medical Technology Co., Ltd. Report for the Third Quarter of 2024
Xi\'an Kangtuo Medical Technology Co., Ltd. Report for the Third Quarter of 2024
Kangtuo Medical (688314.SH) released its performance for the first three quarters, with a net income of 76.71 million yuan, a year-on-year increase of 19.22%.
Kangtuo Medical (688314.SH) disclosed the third quarter report of 2024, achieving a revenue of 2...
Kangtuo Medical (688314.SH): The net income in the first three quarters is about 76.71 million yuan, an increase of 19.22% year-on-year.
Kangtuo Medical (688314.SH) announced on October 28 that its revenue in the first three quarters of 2024 was approximately 0.24 billion yuan, an increase of 16.22% year-on-year; the net income attributable to shareholders of the listed company was approximately 76.71 million yuan, an increase of 19.22% year-on-year; and the basic earnings per share was 0.94 yuan.
